PMH16 AN ECONOMIC EVALUATION OF ARIPIPRAZOLE VERSUS OLANZAPINE IN A SWEDISH SETTING USING OUTCOMES OF METABOLIC SYNDROME, PROJECTED DIABETES AND CORONARY HEART DISEASE
Abstract
Authors
A Ruppert R Waldeck P Cislo K Pugner T Iwamoto Y Yuan U sby